The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels
- 37 Downloads
The purpose of this study were to compare the levels of serum cortisol, aldosterone, testosterone, dehydroepiandrosterone (DHEA), and renin hormone between patients with central serous chorioretinopathy (CSC) and a control group, and to investigate whether there was a difference regarding serum hormone levels in patients with acute/chronic CSC.
This prospective study included 30 CSC eyes, 30 fellow eyes, and 32 normal eyes of 32 healthy volunteers who were age and sex matched. The patients were classified as acute or chronic depending on the clinical, fluorescein angiography (FFA), and optical coherence tomography (OCT) findings. Serum cortisol, aldosterone, renin, total testosterone, and DHEA levels were measured. The levels of hormones were compared with the values of the control group. Choroidal thickness and central macular thickness were measured with spectral domain OCT.
Fifteen patients had acute CSC, and 15 patients had chronic CSC. Serum testosterone levels were 357 ± 10.4 ng/ml in the CSC group, and 255.94 ± 7.43 ng/ml in the control group. The difference between them was statistically significant (p < 0.001). The difference between the levels of cortisol, renin, aldosterone, and DHEA was not statistically significant. Serum hormone levels were within the normal range for all patients and were not statistically different between the acute and chronic CSC groups.
According to our results, CSC is related to elevated total testosterone levels. Testosterone may play a role in predisposing males to CSC.
KeywordsCentral serous chorioretinopathy Cortisol Testosterone Aldosterone Renin
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 4.Gass JDM (1997) Stereoscopic atlas of macular diseases, 4th edn. Mosby, St. Louis, MO, pp 760–763Google Scholar
- 24.Yang LH, Tian B, Shi XH, Ding N, Zhou D, Wei WB (2012) Changes in choroidal thickness in central serous chorioretinopathy. Zhonghua Yan Ke Za Zhi 48:872–877Google Scholar
- 25.Watanabe S, Ohtsuki K (1979) Experimental serous chorioretinopathy. Ada Soc Ophthalmol Jpn 83(7):808–817Google Scholar
- 26.Yoshioka H (1991) The etiology of central serous chorioretinopathy. Ada Soc Ophthalmol Jpn 95(12):1181–1195Google Scholar
- 34.Conway MD, Noble JA, Peyman GA (2016) Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone. Retin Cases Brief Rep 0:1–5Google Scholar